Prenatal cannabis use and the risk of attention deficit hyperactivity disorder and autism spectrum disorder in offspring: A systematic review and meta-analysis

Journal of Psychiatric Research

Volume 171, March 2024, Pages 142-151

Author links open overlay panel Abay Woday Tadesse ac

, Berihun Assefa Dachew a

, Getinet Ayano a

, Kim Betts a

https://doi.org/10.1016/j.jpsychires.2024.01.045Get rights and content

Under a Creative Commons license

Abstract

Background

It is plausible that exposure to cannabis in-utero could be associated with an increased risk of neurodevelopmental disorders such as attention deficit hyperactivity disorder (ADHD) symptoms and autism spectrum disorder (ASD) during childhood and adolescence; however, mixed results have been reported. This study investigated whether there is an association between prenatal cannabis use and ADHD symptoms and ASD in offspring using a systematic review and meta-analysis methodology.

Methods

A systematic literature search was conducted in PubMed/Medline, Scopus, EMBASE, Web of Science, Psych-Info, and Google Scholar to identify relevant studies. The study protocol has been preregistered in the Prospective Register of Systematic Reviews (PROSPERO) (CRD42022345001), and the Newcastle-Ottawa Quality Assessment Scale (NOS) was used to assess the methodological quality of included studies. An inverse variance weighted random effect meta-analysis was conducted to pool the overall effect estimates from the included studies.

Results

Fourteen primary studies, consisting of ten on ADHD and four on ASD, with a total of 203,783 participants, were included in this study. Our meta-analysis underscores an increased risk of ADHD symptoms and/or disorder [β = 0.39: 95 % CI (0.20–0.58), I2 = 66.85 %, P = 0.001)] and ASD [RR = 1.30: 95 % CI (1.03–1.64), I2 = 45.5 %, P = 0.14] associated with in-utero cannabis exposure in offspring compared to their non-exposed counterparts. Additionally, our stratified analysis highlighted an elevated risk of ADHD symptoms [β = 0.54: 95 % CI (0.26–0.82)] and a marginally significant increase in the risk of diagnostic ADHD among exposed offspring compared to non-exposed counterparts [RR = 1.13, 95 % CI (1.01, 1.26)].

Conclusion

This study indicated that maternal prenatal cannabis exposure is associated with a higher risk of ADHD symptoms and ASD in offspring.

addrc

Recent Posts

You May Forgive, But Why Can’t You Ever Forget?

Why is it that even after we’ve made peace with someone’s actions, the memory lingers?…

2 days ago

Can People with ADHD Really Transform Their Lives? The Science Says Yes

Knowing that ADHD is manageable flips the script from despair to possibility. It’s not just…

5 days ago

Is their a relationship between ultra processed food and ADHD

If you care about your cognitive health or that of your children, understanding the impact…

7 days ago

ADHD Isn’t a Superpower—And That’s Okay: Real Talk for Teens

As a teen with ADHD, you're navigating school, friendships, family expectations, and your own identity—all…

1 week ago

How to Talk with Authority When Your ADHD Might Make It Hard

Harold Robert Meyer | The ADD Resource Center 06/21/2025 Executive Summary Speaking with authority can…

1 week ago

Thriving in Solitude: Unlocking the Benefits of Alone Time

Harold Robert Meyer | The ADD Resource Center 06/20/25 Executive Summary In a world that…

1 week ago